Latest filing published 03 Jun 2019 for Quorum Health Corp.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
James T. Breedlove: trading record in brief
Filings by James T. Breedlove span 2 companies, the busiest being Praxair Inc and Quorum Health Corp. Over a trading history stretching from 26 February 2007 to 31 May 2019, the count stands at 75 filings.
In open-market terms, that means 23 purchases worth €1.4M on one side and 18 sales worth €21.8M on the other. Taken together, the sales exceed the purchases by €20.4M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 12 share grants and 21 option exercises.
Half of the purchases are above €44k and half below.
On 3 June 2019 came the latest disclosure, a share grant in Quorum Health Corp. The latest purchase dates back some time: it was published 3,824 days ago, on 20 May 2016. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to James T. Breedlove
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 43,478 shares0Common stock, par value $0.0001 per shareSEC:0001493152-19-008606:0
- 20,630 shares0Common stock, par value $0.0001 per shareSEC:0001209191-18-018930:0
- 28,103 shares0Common stock, par value $0.0001 per shareSEC:0001209191-17-029088:0
- 10,000 shares@ US$11.4448.0% of flowCommon stock, par value $0.0001 per shareSEC:0001209191-16-122153:0Canonical exit: 17 Aug 2016 (T+90)
- 10,000 shares@ US$12.3952.0% of flowCommon stock, par value $0.0001 per shareSEC:0001209191-16-122153:1Canonical exit: 18 Aug 2016 (T+90)
- 10,000 shares0Common stock, par value $0.0001 per shareSEC:0001209191-16-117914:0
- 4,120 shares@ US$60.92Common StockSEC:0000884905-14-000094:0
- 4,120 shares@ US$126.52Common StockSEC:0000884905-14-000094:1
- 10,000 shares@ US$76.16Common StockSEC:0000884905-14-000063:0
- 10,000 shares@ US$130.66Common StockSEC:0000884905-14-000063:1
- 8,000 shares@ US$76.16Common StockSEC:0000884905-14-000063:2
- 8,000 shares@ US$130.61Common StockSEC:0000884905-14-000063:3
- 8,200 shares0Common StockSEC:0000884905-14-000022:0
- 3,990 shares@ US$128.07Common StockSEC:0000884905-14-000022:1
- 40,000 shares@ US$60.92Common StockSEC:0000884905-14-000008:0
- 40,000 shares@ US$129.83Common StockSEC:0000884905-14-000008:1
- 2,000 shares@ US$123.95Common StockSEC:0000884905-13-000116:0
- 4,000 shares@ US$118.60Common StockSEC:0000884905-13-000098:0
- 10,119 shares0Common StockSEC:0000884905-13-000026:0
- 4,252 shares@ US$111.17Common StockSEC:0000884905-13-000026:1
- 244 shares@ US$111.17Common StockSEC:0000884905-13-000026:2
- 10,000 shares@ US$60.92Common StockSEC:0000884905-12-000073:0
- 10,000 shares@ US$107.65Common StockSEC:0000884905-12-000073:1
- 13,584 shares0Common StockSEC:0000884905-12-000023:0
- 5,862 shares@ US$109.88Common StockSEC:0000884905-12-000023:1
25 of 73 declarations
